Follow-up on thyroidal uptake after radioiodine therapy – how robust is the peri-therapeutic dosimetry?

Weetman, 2007, Radioiodine treatment for benign thyroid diseases, Clin Endocrinol (Oxf)., 66, 757, 10.1111/j.1365-2265.2007.02841.x Salvatori, 2010, Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma, Eur J Nucl Med Mol Imaging., 37, 821, 10.1007/s00259-010-1398-0 Council Directive 97/43/Euratom of 30 June 1997 on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure. http://ec.europa.eu/energy/nuclear/radioprotection/doc/legislation/9743_en.pdf Directive „Strahlenschutz in der Medizin“ of 24 June 2002 complementing German radiation protection ordinance. GMBl. 2003, S. 227. http://www.bmu.de/files/pdfs/allgemein/application/pdf/revision02.pdf Breustedt, 2010, Monte Carlo calibration of whole-body counters with NaI(Tl) detectors in stretcher geometry, Radiat Prot Dosimetry., 139, 510, 10.1093/rpd/ncp296 Breustedt, 2004, [Calibration of a whole body counter using Monte Carlo methods], Z Med Phys., 14, 85, 10.1078/0939-3889-00207 Eschner, 2004, [Peri- and pretherapeutic dosimetry in radioiodine therapy of benign thyroid diseases], Nuklearmediziner., 27, 90, 10.1055/s-2004-822681 Dietlein, 2007, Guideline for radioiodine therapy for benign thyroid diseases (version 4), Nuklearmedizin., 46, 220, 10.1160/nukmed-0287 Dietlein, 2007, Procedure guideline for radioiodine test (version 3), Nuklearmedizin., 46, 198, 10.1160/nukmed-0283 Stokkel, 2010, EANM procedure guidelines for therapy of benign thyroid disease, Eur J Nucl Med Mol Imaging., 37, 2218, 10.1007/s00259-010-1536-8 Hänscheid H, Lassmann M, Reiners C. Dosimetry prior to I-131 Therapy of Benign Thyroid Disease. Z Med Phys. 2011;21:##. Kobe, 2010, Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?, Nucl Med Commun, 31, 201, 10.1097/MNM.0b013e328333d303